Table 3.
Time | Group C (n = 36) | Group NBH (n = 37) | Group HBOT (n = 37) | P value | |
---|---|---|---|---|---|
T1 | MoCA | 15.1 ± 1.8 | 15.4 ± 2.0 | 15.5 ± 2.1 | .361 |
MMSE | 16.7 ± 2.4 | 16.9 ± 2.6 | 16.7 ± 2.5 | .544 | |
T2 | MoCA | 18.4 ± 2.0* | 21.3 ± 2.3*,† | 21.7 ± 2.4*,† | .012 |
MMSE | 18.9 ± 2.4* | 21.5 ± 2.8*,† | 21.9 ± 2.8*,† | .008 | |
T3 | MoCA | 19.9 ± 2.6* | 21.9 ± 2.3*,† | 24.9 ± 3.0*,†‡ | <.001 |
MMSE | 20.4 ± 2.7* | 22.3 ± 2.4*,† | 25.3 ± 3.1*,†,‡ | <.001 |
T1: 0 min prior to hyperbaric oxygenation or hyperbaric oxygenation, T2: 0 min after hyperbaric oxygen therapy or hyperbaric oxygen therapy, T3: 30 days after hyperbaric oxygen therapy or hyperbaric oxygen therapy.
HBOT = hyperbaric oxygen therapy, MoCA = Montreal Cognitive Function Assessment; MMSE = mini-mental state examination, NBH = normobaric hyperoxia.
Compared with T1, P < .05.
Compared with Group C, P < .05.
Compared with Group NBH, P < .05.